The United States is witnessing strong advancements in the management of multiple sclerosis, supported by increasing awareness, early diagnosis, and the availability of innovative disease-modifying therapies. Rising prevalence of autoimmune neurological disorders, robust investments in neuroscience research, and continuous development of biologics and targeted therapies are improving treatment...